In a multicenter, randomized, double-blind, placebo-controlled, parallel-group study involving12,000 overweight and obese patients with cardiovascular disease or multiple cardiovascular risk factors (CAMELLIA-TIMI 61), the effect of long-term treatment with lorcaserin on major cardiovascular events and conversion to T2DM over a 5-year period were examined
Post-hoc analysis of the ADAPT study has also revealed a sustained effect of efgartigimod across repeated treatment cycles, demonstrating its efficacity as a long-term treatment option [230]
Learn more in our complete retatrutide research guide
I feel it's to protect the supplier regarding law suits
"BPC 157 and the gut-brain axis: Implications for neuroprotection and mental health." Front Neurosci
What Makes a High Quality BPC-157 Research Peptides